市场调查报告书
商品编码
1547504
全球干眼症治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Dry Eye Disease Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球干眼症治疗市场需求预计将从2023年的59.9亿美元达到2032年近89.4亿美元的市场规模,2024-2032年研究期间复合年增长率为4.55%。
干眼症是一个术语,定义感染者眼睛表面缺乏润滑或水分。这是一种常见的疾病,几乎可以影响任何人。干眼症的症状很多,包括疼痛和灼热感、眼睛发红、眼睛疲劳、眼睛发痒、畏光、眼睛酸痛、流泪等。 、吸烟、LASIK 眼科手术、荷尔蒙替代疗法等。
过度使用智慧型手机和电脑、人口老化(极易患有干眼症)以及其他风险因素正在主导干眼症治疗市场。根据《2019 年世界人口展望》估计,全球约 9% 的人口年龄在 65 岁以上,到 2050 年,这一比例预计将占全球人口的近 17%。患有糖尿病、甲状腺疾病、红斑性狼疮、硬皮症、干燥症、类风湿性关节炎等疾病的人罹患干眼症的风险很高。这些疾病盛行率的扩大往往会导致干眼症发生率的上升。意识水平的提高、诊断率的提高、更好的治疗选择的可用性是促进市场成长的其他因素。然而,患者自我药疗的盛行以及对干眼症的认识较低可能会成为市场的限制。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球干眼症治疗市场的各个细分市场进行了包容性评估。干眼症治疗产业的成长和趋势为本研究提供了整体方法。
干眼症治疗市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲干眼症治疗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。干眼症治疗市场的主要参与者包括诺华公司、艾尔建、Bausch Health Companies Inc.、参天製药有限公司、OASIS Medical。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Dry Eye Disease Treatment Market is presumed to reach the market size of nearly USD 8.94 Billion by 2032 from USD 5.99 Billion in 2023 with a CAGR of 4.55% under the study period 2024-2032.
Dry eye disease is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a usually occurring disease that can affect almost anyone. Numerous dry eye symptoms include aching and burning sensations, red eyes, tired eyes, itchy eyes, photophobia, sore eyes, watery eyes, etc. Factors causing dry eye syndrome include excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Excessive use of smartphones & computers, expanding aging population, which is highly prone to the syndrome, and other risk factors are steering the dry eye disease treatment market. As per World Population Prospects 2019 estimates, around 9% of the global population is over 65 years of age, and by 2050 this is expected to account for nearly 17% of the worldwide population. Individuals with diseases such as diabetes, thyroid disorders, lupus, scleroderma, Sjogren's syndrome, rheumatoid arthritis are at high risk of causing dry eye disease. Expanding prevalence of these diseases will tend to cause a rise in the incidence of dry eye disease. Increasing awareness levels, rising diagnostic rates, availability of better treatment options are other factors augmenting the market's growth. However, the prevalence of self-medication by patients and low awareness about dry eye disease are likely to act as market restraints.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Dry Eye Disease Treatment. The growth and trends of Dry Eye Disease Treatment industry provide a holistic approach to this study.
This section of the Dry Eye Disease Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Dry Eye Disease Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dry Eye Disease Treatment market include Novartis AG, Allergan, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., OASIS Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.